RESUMEN

Cutaneous leishmaniasis is a protozoan infectious disease and widespread in Mediterranean basin including Turkey. Lesions usually start with erythematous papules, gradually enlarges and afterwards it ulcerates. We present a 12-year-old boy with diffuse persistent lip swelling mimicking granulomatous cheilitis. Systemic glucantime was started. However, severe hypotension and bradycardia was developed after injection. Oral fluconazole was started and the lesion resolved completely. Cutaneous leishmaniasis can have varied clinical manifestations and should be suspected especially in endemic areas. Oral fluconazole seems to be safe and effective treatment modality in paediatric cases.

Asunto(s)

Antiprotozoarios/uso terapéutico , Fluconazol/uso terapéutico , Leishmaniasis Cutánea/diagnóstico , Meglumina/uso terapéutico , Compuestos Organometálicos/uso terapéutico , Antiprotozoarios/efectos adversos , Niño , Diagnóstico Diferencial , Humanos , Leishmaniasis Cutánea/tratamiento farmacológico , Labio/patología , Masculino , Meglumina/efectos adversos , Antimoniato de Meglumina , Síndrome de Melkersson-Rosenthal/diagnóstico , Compuestos Organometálicos/efectos adversos , Resultado del Tratamiento